(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(-0.67%) $83.29
(-1.16%) $1.619
(-0.01%) $2 346.90
(-0.07%) $27.52
(0.17%) $923.70
(-0.08%) $0.934
(-0.01%) $11.02
(-0.12%) $0.799
(0.00%) $92.17
3 days till quarter result
(bmo 2024-05-02)
Expected move: +/- 6.61%
@ $80.96
Utstedt: 25 apr 2024 @ 21:38
Avkastning: 0.01%
Forrige signal: apr 25 - 18:49
Forrige signal:
Avkastning: 0.63 %
Live Chart Being Loaded With Signals
Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally...
Stats | |
---|---|
Dagens volum | 435 170 |
Gjennomsnittsvolum | 831 755 |
Markedsverdi | 11.15B |
EPS | $0 ( 2024-02-13 ) |
Neste inntjeningsdato | ( $0.460 ) 2024-05-02 |
Last Dividend | $0.0500 ( 2024-02-29 ) |
Next Dividend | $0 ( N/A ) |
P/E | 27.92 |
ATR14 | $1.870 (2.31%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-12-16 | Laukien Frank H | Sell | 1 404 | Common Stock |
2024-03-04 | Requardt Hermann Fritz | Buy | 10 000 | Common Stock |
2024-03-04 | Requardt Hermann Fritz | Buy | 5 000 | Common Stock |
2024-03-04 | Requardt Hermann Fritz | Sell | 13 772 | Common Stock |
2024-03-04 | Requardt Hermann Fritz | Sell | 1 228 | Common Stock |
INSIDER POWER |
---|
-31.65 |
Last 100 transactions |
Buy: 483 678 | Sell: 1 126 200 |
Volum Korrelasjon
Bruker Corp Korrelasjon
10 Mest positive korrelasjoner | |
---|---|
SVFA | 0.921 |
SKYA | 0.916 |
AEAC | 0.915 |
PPTA | 0.914 |
ARRW | 0.913 |
AMTBB | 0.912 |
LFAC | 0.911 |
INTE | 0.911 |
ESCA | 0.91 |
HORI | 0.91 |
10 Mest negative korrelasjoner | |
---|---|
BMRA | -0.919 |
BWB | -0.911 |
HRMY | -0.91 |
SLN | -0.906 |
INCR | -0.903 |
SFST | -0.903 |
EQBK | -0.902 |
PEAR | -0.902 |
PMVP | -0.902 |
CSSEP | -0.901 |
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Bruker Corp Korrelasjon - Valuta/Råvare
Bruker Corp Økonomi
Annual | 2023 |
Omsetning: | $2.96B |
Bruttogevinst: | $1.52B (51.17 %) |
EPS: | $2.92 |
FY | 2023 |
Omsetning: | $2.96B |
Bruttogevinst: | $1.52B (51.17 %) |
EPS: | $2.92 |
FY | 2022 |
Omsetning: | $2.53B |
Bruttogevinst: | $1.31B (51.59 %) |
EPS: | $2.00 |
FY | 2022 |
Omsetning: | $2.53B |
Bruttogevinst: | $1.31B (51.59 %) |
EPS: | $2.00 |
Financial Reports:
No articles found.
Bruker Corp Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.0500 (N/A) |
$0.0500 (N/A) |
$0.0500 (N/A) |
$0.0500 (N/A) |
$0.0500 (N/A) |
$0.0500 (N/A) |
$0.0500 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.0400 | 2016-03-02 |
Last Dividend | $0.0500 | 2024-02-29 |
Next Dividend | $0 | N/A |
Payout Date | 2024-03-15 | |
Next Payout Date | N/A | |
# dividends | 33 | -- |
Total Paid Out | $1.410 | -- |
Avg. Dividend % Per Year | 0.21% | -- |
Score | 4.59 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 6.12 | |
Div. Directional Score | 8.92 | -- |
Year | Amount | Yield |
---|---|---|
2016 | $0.160 | 0.68% |
2017 | $0.160 | 0.74% |
2018 | $0.160 | 0.46% |
2019 | $0.160 | 0.55% |
2020 | $0.160 | 0.31% |
2021 | $0.160 | 0.30% |
2022 | $0.200 | 0.25% |
2023 | $0.200 | 0.29% |
2024 | $0.0500 | 0.07% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
OXSQ | Dividend Diamond | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
OXLC | Dividend Royal | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
HRZN | Dividend King | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.144 | 1.500 | 7.12 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.101 | 1.200 | 6.65 | 7.98 | [0 - 0.3] |
returnOnEquityTTM | 0.338 | 1.500 | 7.35 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0.0688 | -1.000 | 9.31 | -9.31 | [0 - 1] |
currentRatioTTM | 1.800 | 0.800 | 6.00 | 4.80 | [1 - 3] |
quickRatioTTM | 0.933 | 0.800 | 9.22 | 7.37 | [0.8 - 2.5] |
cashRatioTTM | 0.406 | 1.500 | 8.85 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.303 | -1.500 | 4.94 | -7.42 | [0 - 0.6] |
interestCoverageTTM | -11.98 | 1.000 | -5.55 | -5.55 | [3 - 30] |
operatingCashFlowPerShareTTM | 2.41 | 2.00 | 9.20 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 1.671 | 2.00 | 9.16 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.936 | -1.500 | 6.26 | -9.38 | [0 - 2.5] |
grossProfitMarginTTM | 0.510 | 1.000 | 4.84 | 4.84 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.149 | 1.000 | 9.02 | 9.02 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.272 | 1.000 | 9.60 | 9.60 | [0.2 - 2] |
assetTurnoverTTM | 0.698 | 0.800 | 8.68 | 6.95 | [0.5 - 2] |
Total Score | 11.71 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 27.58 | 1.000 | 7.32 | 0 | [1 - 100] |
returnOnEquityTTM | 0.338 | 2.50 | 8.30 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 1.671 | 2.00 | 9.44 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0.247 | 1.500 | 3.82 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 2.41 | 2.00 | 9.20 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.0688 | 1.500 | 9.31 | -9.31 | [0 - 1] |
pegRatioTTM | 0.361 | 1.500 | -0.929 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.118 | 1.000 | 9.55 | 0 | [0.1 - 0.5] |
Total Score | 6.12 |
Bruker Corp
Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation has a collaboration with Newomics Inc. on a LC-MS platform for drug discovery. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.